Keywords: novartis, withdraws, vitravene, ma, eu, ophthalmics, europe
Novartis withdraws Vitravene MA in EU
Article | 12 August 2002
Novartis Ophthalmics Europe, a division of Swiss drug major Novartis,has voluntarily withdrawn the European Union Marketing Authorization for Vitravene ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
